APA
Bohn B., Bramlage P., Wagner C., Kaltheuner M., Welp R., Sziegoleit S., Zimmermann A., Reuter H. M., Hummel M., Gloyer J., Holl R. W. & Danne T. (20190621). [Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE]. : Wiener medizinische Wochenschrift (1946).
Chicago
Bohn Barbara, Bramlage Peter, Wagner Christian, Kaltheuner Matthias, Welp Reinhard, Sziegoleit Stefan, Zimmermann Artur, Reuter Hans Martin, Hummel Michael, Gloyer Jörg, Holl Reinhard W and Danne Thomas. 20190621. [Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE]. : Wiener medizinische Wochenschrift (1946).
Harvard
Bohn B., Bramlage P., Wagner C., Kaltheuner M., Welp R., Sziegoleit S., Zimmermann A., Reuter H. M., Hummel M., Gloyer J., Holl R. W. and Danne T. (20190621). [Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE]. : Wiener medizinische Wochenschrift (1946).
MLA
Bohn Barbara, Bramlage Peter, Wagner Christian, Kaltheuner Matthias, Welp Reinhard, Sziegoleit Stefan, Zimmermann Artur, Reuter Hans Martin, Hummel Michael, Gloyer Jörg, Holl Reinhard W and Danne Thomas. [Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE]. : Wiener medizinische Wochenschrift (1946). 20190621.